secwatch.observer — SEC 8-K summary
======================================

Issuer:     Silo Pharma, Inc. (SILO)
CIK:        0001514183
Form:       8-K
Filed at:   2023-02-03T23:59:59+00:00
Accession:  0001213900-23-007755
Event type: regulatory
Sentiment:  positive
Materiality: 0.65
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Silo Pharma receives U.S. patent covering SPC-15 for stress-induced affective disorders
--------------------------------------------------------------------------------

- USPTO issued U.S. Patent 11,491,120 for SPC-15, a prophylactic using ketamine for anxiety and PTSD in females.
- Patent protects method of treatment and prevention for stress-induced affective disorders including PTSD.
- Silo holds option to license assets from Columbia University including potential treatments for Alzheimer's disease.
- CEO Eric Weisblum highlighted scope of allowed claims and market potential for SPC-15.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1514183/000121390023007755/0001213900-23-007755-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1514183/000121390023007755/ea172649-8k_silopharma.htm
  HTML page:      https://secwatch.observer/filing/0001213900-23-007755

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer